Resources

Past Presentation

Buprenorphine Long-Acting Injectables | April 16, 2024

Date of Presentation: April 16, 2024

In this presentation, LCDR Draude, PharmD, describes the available buprenorphine Long-Acting Injectable (LAI) agents. LCDR Draude compares and contrasts the LAIs, including dosing and clinical considerations, and discusses the use of LAIs as an approach towards treating opioid use disorder.

Recording:

Presented by:

LCDR Trey Draude, PharmD, BCPP, AAHIVP

LCDR Trey Draude, PharmD, BCPP, AAHIVP, is a Lead Substance Use Disorder Clinical Pharmacist Consultant for the Bureau of Prisons.

Resources Provided:

Date added: April 8, 2024